Clinical Trials

Showing 1 - 20 of 496 trials
Titlesort icon Investigator Disease(s)
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Genotype-Phenotype Urothelial Cancer Study
[Protocol 09-025]
Bajorin, Dean
  • Bladder Cancer
  • Hereditary Cancer & Genetics
A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma
[Protocol 12-249]
Goldfarb, Shari
  • Breast Cancer
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
  • Survivorship
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
[Protocol 12-267]
Hudis, Clifford
  • Breast Cancer
  • Survivorship
A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas
[Protocol 10-049]
Gounder, Mrinal
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031]
Kollmeier, Marisa
  • Bladder Cancer
A Phase I Study Assessing the Effects of Food and Formulation on the Processing of KPT-330 in Patients with Sarcoma
[Protocol 13-145]
Gounder, Mrinal
  • Primary Bone
    • Osteosarcoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase I Study of ABT-199 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 11-152]
Gerecitano, John
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of AEB071 in Patients with Metastatic Uveal Melanoma
[Protocol 11-167]
Carvajal, Richard
  • Melanoma
    • Melanoma of the Eye
A Phase I Study of AG-221 in Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndromes with an IDH2 Mutation
[Protocol 13-154]
Stein, Eytan
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors
[Protocol 13-224]
Autio, Karen
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer
  • Melanoma
  • Ovarian Cancer
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229]
Young, James
  • Melanoma
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Multiple Myeloma as Consolidation Treatment after Autologous Stem Cell Transplantation
[Protocol 13-009]
Chung, David
  • Hematology
    • Multiple Myeloma
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011]
Modak, Shakeel
  • Neuroblastoma
A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049]
Dickler, Maura
  • Breast Cancer
A Phase I Study of ASP8273 in Patients with Non-Small Cell Lung Cancer and EGFR Mutations
[Protocol 14-128]
Yu, Helena
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
Relapsed/Refractory
[Protocol 12-151]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233]
Bell-McGuinn, Katherine
  • Breast Cancer
  • Ovarian Cancer
A Phase I Study of BKM120 with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 10-192]
Fury, Matthew
A Phase I Study of BMS-906024 in Adult and Pediatric Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
Relapsed/Refractory
[Protocol 11-181]
Douer, Dan
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma